Skip to main content
. 2015 May 22;17(5):231. doi: 10.1007/s11051-015-3029-y

Fig. 3.

Fig. 3

Estimated bioavailability of 50 nm PS-NPs, expressed as a percentage of the administered dose (125 mg/kg bw), calculated by summing up the amounts of PS-NPs detected in all analysed organs, except the stomach- and intestinal walls and brain. (0) neutral PS-NPs, (+) positively charged PS-NPs, (−M) and (−P) negatively charged PS-NPs from Magsphere and Polysciences, respectively. Error bars show the standard error of mean (n = 5)